Morneau’s unwise decision to backtrack pharmacare, Walkom, March 2

Every parent knows this: If you aren’t really going to take your kids to the zoo, don’t mention it at all.

When we heard details included in the Liberal’s budget this week, we were delighted. That evening’s conversation around our dining-room table with our adult children was animated and optimistic. One of the most exciting elements in the budget was the announcement of the government’s commitment to pharmacare.

Then, came Finance Minister Bill Morneau’s near-immediate dialing back: not a “plan” exactly, more of a “strategy,” and other weasely sounding words. What a colossal disappointment.

I reluctantly excused the Liberal’s backtrack from their promise to reform our electoral system. Please don’t let the pharmacare “promise” go the same way. We need to hear their clarification and recommitment — and soon. Just be straight with us. Are we going to the zoo or aren’t we?

Jeannie Mackintosh, St. Catherines, Ont.

I was even encouraged by the enlistment of former Ontario health minister Eric Hoskins, whose provincial government recently implemented a long-overdue pharmacare program, albeit one only covering residents under age 25. It was a start and I hoped that coverage would increase eventually to provide coverage for all.

My feelings of elation and hope were soon dashed when Finance Minister Bill Morneau announced it wouldn’t be universal but would amount to a patchwork of coverage, with some people included in the government plan and others not.

This is unacceptable. We don’t need some mish-mash of a program. Let’s do it right and make a universal plan and, as the research indicated, the overall cost to health care should see a reduction. Perhaps Australia’s government could advise how best to meet this goal.

Norah Downey, Midland, Ont.

The announcement of this strategy apparently rejects consideration of any other alternative by the advisory group chaired by Dr. Eric Hoskins. If this is the case, it will be unfortunate because many studies in Canada (and experience in other countries) have demonstrated there are more universal, comprehensive and less-expensive ways of dealing with this issue. I hope the advisory group will give this matter the inclusive study it deserves.

Bill Wensley, Cobourg, Ont.

Drug-policy experts were stunned. Canada is the only advanced country with a medicare system that lacks pharmacare. Canadians spend so much on drugs because we don’t have a pharmacare program: drug prices are too high and too many intermediaries like insurance companies and benefit consultants drain money from the system.

Morneau’s approach would leave all that waste in place. The obstacle is that every dollar wasted is somebody’s income and the affected industries — drug manufacturers, drug insurers and drug benefits managers — fight back.

The minister effectively pointed to a potential conflict of interest and then restricted the mandate of the advisory council. I hope the minister will step back and let the council do its work.

Kim Jarvi, Toronto